These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37276815)

  • 1. Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoring.
    Moideen K; Nathella PK; Madabushi S; Renji RM; Srinivasan P; Ahamed SF; Rajkumar H; Bethunaickan R; Babu S
    Cytokine; 2023 Aug; 168():156238. PubMed ID: 37276815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
    Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
    BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum vitamin D in North Indian multi-drug resistant pulmonary tuberculosis patients: the role of diet and sunlight.
    Rathored J; Sharma SK; Chauhan A; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK
    Ann Med; 2023; 55(2):2291554. PubMed ID: 38079515
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine and soluble adhesion molecule profiles and biomarkers for treatment monitoring in Re-treated smear-positive patients with pulmonary tuberculosis.
    Bai XJ; Li HM; Yang YR; Zhang JX; Liang Y; Wu XQ
    Cytokine; 2018 Aug; 108():9-16. PubMed ID: 29554572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high serum vitamin D concentrations with active pulmonary TB in an HIV co-endemic setting, Harare, Zimbabwe.
    Musarurwa C; Zijenah LS; Duri DZ; Mateveke-Dangaiso K; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
    BMC Infect Dis; 2017 Feb; 17(1):142. PubMed ID: 28193202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Banurekha VV; Nair D; Babu S
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz257. PubMed ID: 31281858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis Sonicate-Induced IFNγ, CXCL10 and IL10 can Differentiate Severity in Tuberculosis.
    Hasan Z; Rao N; Salahuddin N; Islam M; Ashraf M; Rottenberg ME; Hussain R
    Scand J Immunol; 2012 Feb; 75(2):220-6. PubMed ID: 21958213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection.
    Namuganga AR; Nsereko M; Bagaya BS; Mayanja-Kizza H; Chegou NN
    Immunol Lett; 2023 Jan; 253():8-18. PubMed ID: 36463987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.
    Yadav BK; Shah AK; Karunanand B; Sudan DS; Sharma M
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):33-37. PubMed ID: 36148507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.
    Hasan Z; Cliff JM; Dockrell HM; Jamil B; Irfan M; Ashraf M; Hussain R
    PLoS One; 2009 Dec; 4(12):e8459. PubMed ID: 20041183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania.
    Friis H; Range N; Changalucha J; Praygod G; Jeremiah K; Faurholt-Jepsen D; Krarup H; Mølgaard C; Andersen Å
    PLoS One; 2013; 8(12):e81142. PubMed ID: 24324666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxy vitamin D3 downregulates pro-inflammatory cytokine response in pulmonary tuberculosis.
    Harishankar M; Afsal K; Banurekha VV; Meenakshi N; Selvaraj P
    Int Immunopharmacol; 2014 Nov; 23(1):148-52. PubMed ID: 25194676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
    Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S
    Front Immunol; 2020; 11():419. PubMed ID: 32218787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Cytokine; 2020 Jan; 125():154824. PubMed ID: 31472402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay.
    Russomando G; Sanabria D; Díaz Acosta CC; Rojas L; Franco L; Arenas R; Delogu G; Ndiaye MDB; Bayaa R; Rakotosamimanana N; Goletti D; Hoffmann J
    Front Immunol; 2024; 15():1308015. PubMed ID: 38545118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis.
    Kumar NP; Gopinath V; Sridhar R; Hanna LE; Banurekha VV; Jawahar MS; Nutman TB; Babu S
    PLoS One; 2013; 8(3):e59572. PubMed ID: 23544075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis.
    Saghazadeh A; Rezaei N
    J Interferon Cytokine Res; 2022 Mar; 42(3):95-107. PubMed ID: 35298290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.